Topics

AstraZeneca sells US, Canada rights of Seroquel drugs to Cheplapharm

05:58 EST 4 Dec 2019 | Pharmaceutical Business Review

The transaction has been taken up by AstraZeneca as the compound patent protection of the two drugs is no longer valid in the two countries. It would also

The post AstraZeneca sells US, Canada rights of Seroquel drugs to Cheplapharm appeared first on Pharmaceutical Business review.

Original Article: AstraZeneca sells US, Canada rights of Seroquel drugs to Cheplapharm

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca sells US, Canada rights of Seroquel drugs to Cheplapharm"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...